📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model. (2020)

First Author: McAdoo SP

Attributed to: The role of P2X7 in Autoimmune Vasculitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.kint.2019.12.014

PubMed Identifier: 32305129

Publication URI: http://europepmc.org/abstract/MED/32305129

Type: Journal Article/Review

Volume: 97

Parent Publication: Kidney international

Issue: 6

ISSN: 0085-2538